XBiotech Inc. (XBIT) — Institutional Holders, Q2 2026

36 institutional investment managers reported a XBIT position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $4.6M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

XBIT in Q2 2026: what funds did

Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.

New positions

3

Added to

5

Trimmed

12

Sold out

3

Biggest buyers

  1. GSA CAPITAL PARTNERS LLPNew · +30,654 sh+$70.5K
  2. CITADEL ADVISORSNew · +29,192 sh+$67.1K
  3. BlackRockAdded · +28,042 sh+$64.5K
  4. RENAISSANCE TECHNOLOGIESAdded · +19,225 sh+$44.2K
  5. Qube Research & Technologies LtdAdded · +14,879 sh+$34.2K

Biggest sellers

  1. JANE STREET GROUPTrimmed · -48,624 sh-$111.8K
  2. MILLENNIUM MANAGEMENTTrimmed · -26,210 sh-$60.3K
  3. MORGAN STANLEYTrimmed · -17,674 sh-$40.6K
  4. GEODE CAPITAL MANAGEMENTTrimmed · -16,904 sh-$38.9K
  5. BANK OF AMERICATrimmed · -12,900 sh-$29.7K

XBIT 13F holders ranked 1–36 of 36

Institutional investors reporting a position in XBiotech Inc. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
BlackRock#1 · 321,146 sh$738.6K+9.6%
GEODE CAPITAL MANAGEMENT#2 · 214,116 sh$492.8K-7.3%
VANGUARD CAPITAL MANAGEMENT#3 · 200,182 sh$460.4K-0.4%
RBF Capital#4 · 198,501 sh$456.6K0.0%
MORGAN STANLEY#5 · 147,880 sh$340.1K-10.7%
BRIDGEWAY CAPITAL MANAGEMENT#6 · 98,447 sh$226.4K0.0%
VANGUARD FIDUCIARY#7 · 92,365 sh$212.4K+0.9%
MILLENNIUM MANAGEMENT#8 · 79,330 sh$182.5K-24.8%
STATE STREET#9 · 73,006 sh$167.9K0.0%
NORTHERN#10 · 66,258 sh$152.4K-12.9%
Empowered Funds#11 · 59,547 sh$137.0K0.0%
RENAISSANCE TECHNOLOGIES#12 · 41,663 sh$95.8K+85.7%
Bank of New York Mellon#13 · 39,355 sh$90.5K0.0%
DIMENSIONAL FUND ADVISORS#14 · 36,053 sh$83.0K0.0%
Squarepoint Ops#15 · 34,757 sh$79.9K-15.7%
Qube Research & Technologies Ltd#16 · 33,570 sh$77.2K+79.6%
GSA CAPITAL PARTNERS LLP#17 · 30,654 sh$71.0KNew
CITADEL ADVISORS#18 · 29,192 sh$67.1KNew
Connor, Clark & Lunn Investment Management Ltd.#19 · 27,943 sh$64.3K-2.5%
BNP PARIBAS FINANCIAL MARKETS#20 · 26,464 sh$60.9K-2.6%
NATIONAL BANK OF CANADA#21 · 25,000 sh$57.5K0.0%
BANK OF AMERICA#22 · 23,789 sh$54.7K-35.2%
AMERICAN CENTURY COMPANIES#23 · 18,381 sh$42.3K-2.6%
Thomasville National Bank#24 · 13,350 sh$30.7K—
XTX Topco Ltd#25 · 13,080 sh$30.1K-26.9%
Pinnacle Financial Partners#26 · 11,796 sh$27.1K0.0%
JANE STREET GROUP#27 · 11,476 sh$26.4K-80.9%
Vanguard Global Advisers#28 · 7,009 sh$16.1K0.0%
UBS Group AG#29 · 5,035 sh$11.6K0.0%
ROYAL BANK OF CANADA#30 · 1,206 sh$3.0K+1.4%
JONES FINANCIAL COMPANIES LLLP#31 · 370 sh$862.000.0%
JPMORGAN CHASE#32 · 96 sh$224.000.0%
BARCLAYS PLC#33 · 94 sh$216.00New
SBI Securities , Ltd.#34 · 37 sh$85.000.0%
Larson Financial Group#35 · 21 sh$48.000.0%
Caitong International Asset Management , Ltd#36 · 11 sh$25.000.0%

Funds that sold out of XBIT in Q2 2026 (3)

Held XBIT at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.

Institutions that held XBIT in Q1 2026 and reported no position in Q2 2026.
InstitutionValue in Q1 2026
RHUMBLINE ADVISERS928 sh$2.2K
SRS Capital Advisors15 sh$35.00
Optiver Holding B.V.8 sh$19.00

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.